Cytokines in symptomatic asthma airways

The Journal of Allergy and Clinical Immunology

Volumn 89, Issue 5, 1992, Pages 958-967

  Broide, David H ^a   Lotz, Martin ^b   Cuomo, Anthony J ^c   Coburn, David A ^c   Federman, Edward C ^c   Wasserman, Stephen I ^a  

^a Division of Allergy   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALVARADO HOSPITAL   (United States)

Author keywords

Asthma; cytokines; GM CSF; IL 1 ; IL 2; IL 6; TNF

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AIRWAY; ASTHMA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE LEVEL;

ASTHMA; BASE SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMAN; INTERLEUKIN-1; INTERLEUKINS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; RESPIRATORY FUNCTION TESTS; RNA; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0026514960     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(92)90218-Q     Document Type: Article

References (27)

1. Mucosal inflammation in asthma
2. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma
3. The eosinophil and the pathophysiology of asthma [Postgrad course]
4. Interleukin-2: inception, impact, and implications
5. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T-lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody
6. Differential expression of tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes
7. Demonstration by in situ hybridization of dissimilar IL-1β gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide
8. Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor
9. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts
10. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3
11. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colonystimulating factor
12. Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae
13. Recombinant human interleukin-5 is a selective activator of human eosinophil function
14. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures
15. Airway levels of mast cell derived mediators in exercise-induced asthma
16. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
17. Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease (COPD) and asthma
18. Inhibition of human bronchial kallikrein in asthma
19. Safety and possible efficacy of fiberoptic bronchoscopy with lavage in the management of refractory asthma with mucous impaction
20. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells
21. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide
22. Quantitation of mRNA by the polymerase chain reaction
23. Cloning, sequence, and expression of two distinct human interleukin-I cDNAs
24. Tumor necrosis factors/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium
25. What can be teamed from the expression of endothelial adhesion molecules in tissues
26. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma
27. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma